Antibodies

(DonkeyWorx/iStock via Getty Images Plus)

Latest FDA updates on COVID-19 battle

By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

Spotlight

(triocean/iStock via Getty Images Plus) GSK rhinosinusitis drug receives thumbs up from the FDA (Vladimir Vladimirov/iStock via Getty Images Plus) Virtual trials more important than ever post-COVID: Florence (BeholdingEye/iStock via Getty Images Plus) Biomarker panel to elevate prostate cancer diagnostics: Berg (Hispanolistic/iStock via Getty Images Plus) Statistical innovation could elevate global clinical trials: Cytel (FatCamera/iStock via Getty Images Plus) Increasingly savvy patients call for shift in trial approach: Illingworth

Follow us

Products

View more

Webinars

Upcoming supplier webinars

On-demand webinars

Featured Suppliers

All suppliers